Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C A Jackson

Showing results (111-120 of 124) with videos related to

Pageof 13
Sort By:
Neuroepidemiology|January 1, 1995
Incidence and risk factors of equine motor neuron disease: an ambidirectional studyR de la Rúa-Doménech, H O Mohammed, J F Cummings, et al.
JCO Oncology Practice|January 11, 2024
Use of Novel National Data Sets to Monitor Chemotherapy Use and Outcomes: A Retrospective Cohort Study of Non-Small-Cell Lung Cancer in Aotearoa New ZealandAlice M Minhinnick, Alexander H Dunn, Vahid Arabnejad, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 21, 2024
Equity of travel to access surgery and radiation therapy for lung cancer in New ZealandJason Gurney, Anna Davies, James Stanley, et al.
The Journal of Bone and Joint Surgery. American Volume|November 4, 1998
Orthopaedic workforce in the next millenniumJ D Heckman, P P Lee, C A Jackson, et al.
The Lancet Regional Health. Western Pacific|March 29, 2021
The impact of the COVID-19 pandemic on cancer diagnosis and service access in New Zealand-a country pursuing COVID-19 eliminationJason K Gurney, Elinor Millar, Alex Dunn, et al.
Clinical Nuclear Medicine|November 1, 1994
Resting Tl-201 scintigraphy in the evaluation of coronary artery disease in children with Hurler syndromeR P du Cret, E J Weinberg, C A Jackson, et al.
BMC Cancer|October 3, 2014
Dose-intense capecitabine, oxaliplatin and bevacizumab as first line treatment for metastatic, unresectable colorectal cancer: a multi-centre phase II studyChristopher G C A Jackson, Katrina Sharples, Paul I Thompson, et al.
Investigational New Drugs|June 27, 2013
Patupilone in patients with pretreated metastatic/locally recurrent colorectal cancer: results of the Phase II CINATRA trialS Y Moorcraft, I Chau, C Peckitt, et al.
Diabetologia|August 16, 2012
Area-based socioeconomic status, type 2 diabetes and cardiovascular mortality in ScotlandC A Jackson, N R V Jones, J J Walker, et al.
CPT: Pharmacometrics & Systems Pharmacology|April 26, 2022
Population pharmacokinetics for oral paclitaxel in patients with advanced/metastatic solid tumorsJimmy He, Christopher G C A Jackson, Sanjeev Deva, et al.
Pageof 13

Showing results (111-120 of 124) with videos related to

Sort By:
Pageof 13
Neuroepidemiology|January 1, 1995
Incidence and risk factors of equine motor neuron disease: an ambidirectional studyR de la Rúa-Doménech, H O Mohammed, J F Cummings, et al.
JCO Oncology Practice|January 11, 2024
Use of Novel National Data Sets to Monitor Chemotherapy Use and Outcomes: A Retrospective Cohort Study of Non-Small-Cell Lung Cancer in Aotearoa New ZealandAlice M Minhinnick, Alexander H Dunn, Vahid Arabnejad, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 21, 2024
Equity of travel to access surgery and radiation therapy for lung cancer in New ZealandJason Gurney, Anna Davies, James Stanley, et al.
The Journal of Bone and Joint Surgery. American Volume|November 4, 1998
Orthopaedic workforce in the next millenniumJ D Heckman, P P Lee, C A Jackson, et al.
The Lancet Regional Health. Western Pacific|March 29, 2021
The impact of the COVID-19 pandemic on cancer diagnosis and service access in New Zealand-a country pursuing COVID-19 eliminationJason K Gurney, Elinor Millar, Alex Dunn, et al.
Clinical Nuclear Medicine|November 1, 1994
Resting Tl-201 scintigraphy in the evaluation of coronary artery disease in children with Hurler syndromeR P du Cret, E J Weinberg, C A Jackson, et al.
BMC Cancer|October 3, 2014
Dose-intense capecitabine, oxaliplatin and bevacizumab as first line treatment for metastatic, unresectable colorectal cancer: a multi-centre phase II studyChristopher G C A Jackson, Katrina Sharples, Paul I Thompson, et al.
Investigational New Drugs|June 27, 2013
Patupilone in patients with pretreated metastatic/locally recurrent colorectal cancer: results of the Phase II CINATRA trialS Y Moorcraft, I Chau, C Peckitt, et al.
Diabetologia|August 16, 2012
Area-based socioeconomic status, type 2 diabetes and cardiovascular mortality in ScotlandC A Jackson, N R V Jones, J J Walker, et al.
CPT: Pharmacometrics & Systems Pharmacology|April 26, 2022
Population pharmacokinetics for oral paclitaxel in patients with advanced/metastatic solid tumorsJimmy He, Christopher G C A Jackson, Sanjeev Deva, et al.
Pageof 13